Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukodepleted blood components

A R Thomson1

  • 1NSW Red Cross Blood Transfusion Service, Sydney, Australia.

Anaesthesia and Intensive Care
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Leukodepleted blood components can minimize transfusion adverse effects by removing contaminating white blood cells (leukocytes). This review covers leukocyte effects, leukodepletion benefits, methods, and usage recommendations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seismic velocities of CaSiO<sub>3</sub> perovskite can explain LLSVPs in Earth's lower mantle.

Nature·2019
Same author

Patents and literature.

Applied biochemistry and biotechnology·2013
Same author

A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin.

Pathology·2001
Same author

Effect of blood donation on the establishment of normal ranges of lymphocyte subsets.

Transfusion·1996
Same author

One-way valve malfunction in a circle system.

Anaesthesia·1995
Same author

Monocyte isolation by flow cytometer-monitored centrifugal elutriation: a preparative tool for antibody-dependent cell-mediated cytotoxicity (ADCC) assays.

British journal of biomedical science·1994
Same journal

Evaluating the completeness of perioperative outcome metrics in electronic medical records: Insights based on the proposed Perioperative Clinical Outcomes Registry framework.

Anaesthesia and intensive care·2026
Same journal

Large language model prompt engineering for medical education: A practical guide for the Australian and New Zealand College of Anaesthetists Final Examination.

Anaesthesia and intensive care·2026
Same journal

Nitrous oxide added at the end of sevoflurane anaesthesia hastens emergence and eliminates prolonged time to extubation (SEVONATE study): A randomised controlled trial.

Anaesthesia and intensive care·2026
Same journal

Complications related to arterial line catheters and monitoring reported to webAIRS, 2009-2023.

Anaesthesia and intensive care·2026
Same journal

A summary guide for detecting and reducing nitrous oxide infrastructure leaks in healthcare facilities.

Anaesthesia and intensive care·2026
Same journal

Is jelly a solid or a clear liquid? A pilot study using ultrasound to assess the gastric emptying of fruit-flavoured gelatin dessert.

Anaesthesia and intensive care·2026
See all related articles

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • Contaminating leukocytes in blood components can cause adverse transfusion reactions.
  • Understanding these effects is crucial for patient safety in transfusion medicine.

Purpose of the Study:

  • To review the adverse effects of passenger leukocytes in blood transfusions.
  • To evaluate the efficacy of leukodepleted blood components in preventing transfusion complications.
  • To summarize leukodepletion methods and current recommendations for their use.

Main Methods:

  • Literature review of studies on leukocyte effects and leukodepletion.
  • Analysis of clinical data regarding transfusion complications.
  • Synthesis of current guidelines and recommendations.

Related Experiment Videos

Main Results:

  • Passenger leukocytes are associated with various transfusion-related adverse events.
  • Leukodepletion effectively reduces the incidence of certain transfusion complications.
  • Different methods exist for leukodepletion, each with varying efficiencies.

Conclusions:

  • Leukodepleted blood components offer significant clinical benefits by mitigating transfusion risks.
  • Implementing leukodepletion strategies is recommended in specific clinical scenarios.
  • Further research may refine leukodepletion techniques and expand their application.